These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25833121)

  • 1. Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
    Lönnberg S; Hansen BT; Haldorsen T; Campbell S; Schee K; Nygård M
    Int J Cancer; 2015 Oct; 137(7):1758-64. PubMed ID: 25833121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
    Hansen BT; Campbell S; Nygård M
    BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
    Mathew A; George PS
    Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia.
    Stockton D; Cooper P; Lonsdale RN
    J Med Screen; 1997; 4(1):40-3. PubMed ID: 9200062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old.
    Chan PG; Sung HY; Sawaya GF
    Obstet Gynecol; 2003 Oct; 102(4):765-73. PubMed ID: 14551007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical adenocarcinoma: moving towards better prevention.
    Seoud M; Tjalma WA; Ronsse V
    Vaccine; 2011 Nov; 29(49):9148-58. PubMed ID: 21983356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and adenocarcinoma of the cervix.
    Sasieni P; Castanon A; Cuzick J
    Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R; Sparén P; Adami HO
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
    Robertson JH; Woodend B
    Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.
    Chaturvedi AK; Kleinerman RA; Hildesheim A; Gilbert ES; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fossa SD; Joensuu H; Travis LB; Engels EA
    J Clin Oncol; 2009 Feb; 27(6):967-73. PubMed ID: 19114696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer of the uterine cervix in Norway by histologic type, 1970-84.
    Eide TJ
    J Natl Cancer Inst; 1987 Aug; 79(2):199-205. PubMed ID: 3474452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women.
    Bulk S; Visser O; Rozendaal L; Verheijen RH; Meijer CJ
    Int J Cancer; 2005 Mar; 113(6):1005-9. PubMed ID: 15515017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
    Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
    Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
    Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
    PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing incidence of cervical adenocarcinoma in Ontario: is this related to improved endocervical Pap test sampling?
    Howlett RI; Marrett LD; Innes MK; Rosen BP; McLachlin CM
    Int J Cancer; 2007 Jan; 120(2):362-7. PubMed ID: 17072843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.